Company Profile

Nanosurface Biomedical Inc
Profile last edited on: 9/20/2022      CAGE: 7C8Q3      UEI: D6VABZ7RVM84

Business Identifier: Biomimetic cultureware for biomedical and research applications
Year Founded
2015
First Award
2016
Latest Award
2023
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

13757 26th Avenue Ne
Seattle, WA 98125
   (206) 604-9280
   contact@nsurfacebio.com
   www.nanosurfacebio.com
Location: Single
Congr. District: 07
County: King

Public Profile

NanoSurface Biomedical provides products and services for drug development, disease modeling, and fundamental research into cell biology. NanoSurface culture products imitate the native extracellular matrix, and structure cultured cells into physiologically relevant tissue models. The firm develop nanopattern substrates that are printed at the bottom of sterile cell culture dishes - effectively providing a topographical and mechanical niche for cells to grow as if they were in vivo. By mimicking the extracellular environment, this unique Anisotropically NanoFabricated Substratum (ANFS) technology promotes the in vivo-like maturation and alignment of in vitro cell cultures. The NanoSurface Biomedical's nanopatterned cultureware has been validated on various cell types toincluude cardiomyocytes, muscle cells, entothelial cells, iPS cells, mesenchymal stem cells and fibroblasts in in vitro cell cultures.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
15-19
Revenue Range
1.5M-2M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Key People / Management

  Martyn Darby

  Eli Fine

  Elliot Fisher

  Nicholas A Geisse

  Rajneesh Jah

  Alec Simon Tulloch Smith

Company News

There are no news available.